HLA-B*53:01 is a significant risk factor for liver injury due to phenytoin and other anti-epileptic drugs in African Americans
dc.contributor.author | Nicoletti, Paola | |
dc.contributor.author | Dellinger, Andrew | |
dc.contributor.author | Li, Yi-Ju | |
dc.contributor.author | Barnhart, Huiman | |
dc.contributor.author | Phillips, Elizabeth | |
dc.contributor.author | Chalasani, Naga | |
dc.contributor.author | Drug Induced Liver Injury Network (DILIN) investigators | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-03-03T11:51:31Z | |
dc.date.available | 2025-03-03T11:51:31Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Introduction: To investigate human leukocyte antigen alleles associated with liver injury due to antiepileptic drugs (AEDs) in African Americans (AA). Methods: In this study, 21 AA with AED drug-induced liver injury (DILI), 176 AA with DILI due to non-AEDs, and 5816 AA population controls were included. Results: HLA-B*53:01 was significantly associated with aromatic AED-DILI (odds ratio: 4.52, 95% confidence interval: 2.42-8.44, P = 1.46 × 10 -5 ). Phenytoin DILI showed the strongest association with HLA-B*53:01 (odds ratio: 9.17; 95% confidence interval: 3.61-23.28, P = 1.1 × 10 -5 ). The HLA-B*53:01 allele was carried by 8 of 9 AA phenytoin DILI cases. Discussion: HLA-B*53:01 is a significant risk factor of liver injury due to antiepileptics, particularly phenytoin, in AA. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Nicoletti P, Dellinger A, Li YJ, et al. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am J Gastroenterol. 2024;119(1):200-202. doi:10.14309/ajg.0000000000002454 | |
dc.identifier.uri | https://hdl.handle.net/1805/46168 | |
dc.language.iso | en_US | |
dc.publisher | Wolters Kluwer | |
dc.relation.isversionof | 10.14309/ajg.0000000000002454 | |
dc.relation.journal | The American Journal of Gastroenterology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Anticonvulsants | |
dc.subject | Chemical and drug induced liver injury | |
dc.subject | Phenytoin | |
dc.title | HLA-B*53:01 is a significant risk factor for liver injury due to phenytoin and other anti-epileptic drugs in African Americans | |
dc.type | Article |